Show simple item record

dc.contributor.authorWalsh, Garry Michael
dc.date.accessioned2013-04-26T11:30:00Z
dc.date.available2013-04-26T11:30:00Z
dc.date.issued2012-03
dc.identifier.citationWalsh , G M 2012 , ' An update on emerging drugs for asthma ' , Expert Opinion on Emerging Drugs , vol. 17 , no. 1 , pp. 37-42 . https://doi.org/10.1517/14728214.2012.657625en
dc.identifier.issn1472-8214
dc.identifier.otherPURE: 12376619
dc.identifier.otherPURE UUID: 21d1894a-3e55-451b-a11c-1648076c3578
dc.identifier.otherScopus: 84858984498
dc.identifier.urihttp://hdl.handle.net/2164/2818
dc.format.extent6en
dc.language.isoeng
dc.relation.ispartofExpert Opinion on Emerging Drugsen
dc.rightsWalsh, GM 2012, 'An update on emerging drugs for asthma' Expert Opinion on Emerging Drugs, vol 17, no. 1, pp. 37-42. Copyright © 2012 Informa Plc. All rights reserved. DOI: 10.1517/14728214.2012.657625en
dc.subjectasthmaen
dc.subjectIL-13en
dc.subjectIL-4en
dc.subjectIL-5en
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleAn update on emerging drugs for asthmaen
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen, Applied Medicineen
dc.description.statusPeer revieweden
dc.description.versionPreprinten
dc.identifier.doihttps://doi.org/10.1517/14728214.2012.657625


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record